Avantor, Inc.
Avantor, Inc. (AVTR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
avtr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Avantor, Inc. (AVTR) measures how much investors pay for each dollar of the company's trailing earnings. AVTR's current PE ratio of N/A is calculated by dividing its stock price of $9.69 by its TTM earnings per share of -$0.81.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%48.0x
MedianQ3 · 75%358.7x
Max
At N/A, AVTR's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Avantor, Inc.You AVTR | $6.6B | N/A | — | -$0.81 |
 AptarGroup, Inc. ATR | $7.1B | 20.41x | +19.3% | $5.97 |
 Baxter International Inc. BAX | $9.9B | N/A | — | -$1.87 |
 Bio-Rad Laboratories, Inc. BIO | $7.9B | 10.87x | -36.4% | $27.87 |
 Grifols, S.A. GRFS | $6.2B | 14.03x | -18.0% | $0.57 |
 Henry Schein, Inc. HSIC | $8.9B | 23.11x | +35.1% | $3.29 |
 Masimo Corporation MASI | $9.4B | N/A | — | -$2.83 |
Industry Average 4 peers with valid PE | — | 17.10x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.78 | — | |
2024-12-31 FY2024 | 20.15x | $1.05 | -58.1% | |
2023-12-31 FY2023 | 48.03x | $0.48 | +140.2% | |
2022-12-31 FY2022 | 20.00x | $1.05 | -54.0% | |
2021-12-31 FY2021 | 43.46x | $0.97 | -68.8% | |
2020-12-31 FY2020 | 139.13x | $0.20 | -27.8% | |
2019-12-31 FY2019 | 192.64x | $0.09 | — | |
2018-12-31 FY2018 | — | $-0.18 | — | |
2017-12-31 FY2017 | — | $-0.23 | — | |
2016-12-31 FY2016 | — | $-0.09 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Avantor, Inc. (AVTR) measures how much investors pay for each dollar of the company's trailing earnings. AVTR's current PE ratio of N/A is calculated by dividing its stock price of $9.69 by its TTM earnings per share of -$0.81.
Frequently asked questions
AVTR pe ratio · 6 questionsAVTR's current PE ratio is N/A as of 2026-06-08, based on a stock price of $9.69 and TTM EPS of -$0.81. Data sourced from Financial Modeling Prep via AVTR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avantor, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08